Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Indian stock markets trade strong
Thu, 2 May 01:30 pm

Backed by consistent buying activity Indian stock markets continued to trade in the green in the post noon trading session. Majority of the sectoral indices were trading firm. Stocks from the IT and capital goods sectors witnessed maximum buying interest.

BSE-Sensex is up by 255 points and NSE-Nifty is trading up by 80 points. While BSE Mid Cap is trading up by 0.8%, BSE Small Cap index is also trading up by 0.8%. The rupee is trading at 53.71 to the US dollar.

Majority of the food stocks are trading in the green led by GlaxoSmithKline Consumer Healthcare (GSKCH) and United Spirits. However Godfrey Philips and Nestle are among the few losers. GSKCH has announced its results for the quarter ended March 2013. The company posted a 17% YoY rise in topline. However, a sharp rise in ad-spends and staff costs offset the input cost savings from waning commodity inflation. As a result the operating margin contracted by 0.9% to 21.2%. Its profits grew by a faster 18.5% aided by lower interest and depreciation charges. Even its tax outgo increased by a modest 11% due to fall in tax incidence during the quarter.

Most of automobile stocks are trading in the green with Ashok Leyland and Bajaj Auto being the major gainers. As per a leading financial daily, Hero Motorcorp is looking to set up manufacturing facilities in Columbia and Bangladesh. Reportedly, this would be the company's first initiative on manufacturing operations abroad after its termination of the joint venture with former partner Honda Motor Company. Further, it already has distribution partners in both the countries viz., Columbia and Bangladesh. Hero Motorcorp is looking to set up fully fledged manufacturing units in both the countries by the end of the current fiscal. This expansion will help the company increase its market share in these geographies. The company has already started to export its vehicles in central and Latin America and Africa and has appointed new distributors and added channels. The products to be sold in various international markets are in the 100-125 cc range.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Indian stock markets trade strong". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Agora Research Private Limited.

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Agora Research Private Limited (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.